Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methysergide
Drug ID BADD_D01439
Description An ergot derivative that is a congener of lysergic acid diethylamide. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome.
Indications and Usage For the treatment of vascular headache
Marketing Status Discontinued
ATC Code N02CA04
DrugBank ID DB00247
KEGG ID D02357
MeSH ID D008784
PubChem ID 9681
TTD Drug ID D0O6GC
NDC Product Code Not Available
Synonyms Methysergide | Dimethylergometrin | Methylmethylergonovine | UML-491 | UML 491 | UML491 | Sansert | Deseril | Désernil-Sandoz | Désernil Sandoz | Desril | Methysergide Dimaleate | Dimaleate, Methysergide | Methysergide Maleate | Maleate, Methysergide
Chemical Information
Molecular Formula C21H27N3O2
CAS Registry Number 361-37-5
SMILES CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Insomnia17.15.03.002; 19.02.01.002--
Leriche syndrome24.04.01.003--Not Available
Malaise08.01.01.003--
Myalgia15.05.02.001--
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Nausea07.01.07.001--
Neutropenia01.02.03.004--Not Available
Oedema14.05.06.010; 08.01.07.006--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Oliguria20.01.03.004--Not Available
Orthostatic hypotension24.06.03.004; 17.05.01.020--Not Available
Pain08.01.08.004--
Pain in extremity15.03.04.010--
Paraesthesia17.02.06.005--
Peyronie's disease21.12.01.002--Not Available
Pleural effusion22.05.02.002--
Polyuria20.02.03.002--Not Available
Rash23.03.13.001--Not Available
Retroperitoneal fibrosis10.02.01.026; 07.07.03.003; 20.06.01.006--Not Available
Seizure17.12.03.001--
Somnolence19.02.05.003; 17.02.04.006--
Tachycardia02.03.02.007--Not Available
Telangiectasia24.03.03.003; 23.06.03.001--
Thrombocytopenia01.08.01.002--Not Available
Thrombophlebitis24.01.02.001--Not Available
Vomiting07.01.07.003--
Weight decreased13.15.01.005--
Weight increased13.15.01.006--
Red blood cell sedimentation rate increased13.01.03.001--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages